Three Recombinant Engineered Antibodies against Recombinant Tags with High Affinity and Specificity.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26943906)

Published in PLoS One on March 04, 2016

Authors

Hongyu Zhao1, Ao Shen2, Yang K Xiang2, David P Corey1

Author Affiliations

1: Department of Neurobiology and Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
2: Department of Pharmacology, School of Medicine, University of California, Davis, California, United States of America.

Articles cited by this

Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells. Nature (2007) 4.87

Reproducibility: Standardize antibodies used in research. Nature (2015) 4.59

Probing cellular protein complexes using single-molecule pull-down. Nature (2011) 3.92

Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc Natl Acad Sci U S A (1970) 3.48

Nanobodies: natural single-domain antibodies. Annu Rev Biochem (2013) 3.12

Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J Cell Biol (1995) 3.00

Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J Biol Chem (1988) 2.30

Modulation of protein properties in living cells using nanobodies. Nat Struct Mol Biol (2009) 2.15

Imaging of receptor trafficking by using alpha-bungarotoxin-binding-site-tagged receptors. Proc Natl Acad Sci U S A (2004) 2.00

Dependence of effective molarity on linker length for an intramolecular protein-ligand system. J Am Chem Soc (2007) 1.98

Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol Biol Cell (2002) 1.95

Characterization and optimization of peptide arrays for the study of epitope-antibody interactions using surface plasmon resonance imaging. Anal Chem (2002) 1.72

Ligand binding assays at equilibrium: validation and interpretation. Br J Pharmacol (2010) 1.71

Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci U S A (1998) 1.69

A nanobody-based system using fluorescent proteins as scaffolds for cell-specific gene manipulation. Cell (2013) 1.69

A guide to simple and informative binding assays. Mol Biol Cell (2010) 1.67

Quality control of overexpressed membrane proteins. Proc Natl Acad Sci U S A (2008) 1.65

Enhancing antibody Fc heterodimer formation through electrostatic steering effects: applications to bispecific molecules and monovalent IgG. J Biol Chem (2010) 1.60

Antigen recognition by conformational selection. FEBS Lett (1999) 1.42

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth. Int J Cancer (2011) 1.16

Single-molecule imaging reveals transforming growth factor-beta-induced type II receptor dimerization. Proc Natl Acad Sci U S A (2009) 1.14

A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicity. Proc Natl Acad Sci U S A (2001) 1.07

Bispecific designed ankyrin repeat proteins (DARPins) targeting epidermal growth factor receptor inhibit A431 cell proliferation and receptor recycling. J Biol Chem (2011) 1.00

Peptide tags for labeling membrane proteins in live cells with multiple fluorophores. Biotechniques (2005) 0.98

Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity. Chem Biol (2001) 0.92

Soluble Fc fusion proteins for biomedical research. Methods Mol Biol (2007) 0.91

Highly parallel measurements of interaction kinetic constants with a microfabricated optomechanical device. Appl Phys Lett (2009) 0.90

The binding site of acetylcholine receptor: from synthetic peptides to solution and crystal structure. Ann N Y Acad Sci (2003) 0.88

Sequence analysis and bacterial production of the anti-c-myc antibody 9E10: the V(H) domain has an extended CDR-H3 and exhibits unusual solubility. FEBS Lett (1997) 0.85

Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding. Mol Immunol (2010) 0.82